GCH1 mutations in hereditary spastic paraplegia
暂无分享,去创建一个
G. Rouleau | J. Trempe | Z. Gan-Or | N. Dupré | S. Veyron | M. Estiar | G. Yoon | E. Leveille | P. Varghaei | Etienne Leveille | Gan-Or Ziv
[1] R. Helmich,et al. Autosomal dominant GCH1 mutations causing spastic paraplegia at disease onset. , 2020, Parkinsonism & related disorders.
[2] G. Rouleau,et al. Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype , 2020, Molecular genetics & genomic medicine.
[3] Sonja W. Scholz,et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies , 2019, The Lancet Neurology.
[4] V. Álvarez,et al. Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism , 2019, Movement disorders : official journal of the Movement Disorder Society.
[5] J. Vilo,et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..
[6] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[7] O. Monchi,et al. Common and rare GCH1 variants are associated with Parkinson's disease , 2019, Neurobiology of Aging.
[8] Silvio C. E. Tosatto,et al. InterPro in 2019: improving coverage, classification and access to protein sequence annotations , 2018, Nucleic Acids Res..
[9] Alexandros Kouris,et al. VarSome: the human genomic variant search engine , 2018, bioRxiv.
[10] Y. Shimo,et al. GCH1 mutations in dopa-responsive dystonia and Parkinson’s disease , 2018, Journal of Neurology.
[11] K. Xia,et al. Rare GCH1 heterozygous variants contributing to Parkinson's disease. , 2017, Brain : a journal of neurology.
[12] A. Oliveira,et al. Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks , 2016, The Cerebellum.
[13] D. Timmann,et al. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78) , 2017, Brain : a journal of neurology.
[14] O. Suchowersky,et al. Clinical and genetic study of hereditary spastic paraplegia in Canada , 2016, Neurology: Genetics.
[15] J. Jankovic,et al. Dopa-responsive dystonia—clinical and genetic heterogeneity , 2015, Nature Reviews Neurology.
[16] J. Jankovic,et al. SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa‐Responsive Dystonia , 2015, Movement disorders clinical practice.
[17] Y. Furukawa. GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia , 2015 .
[18] T. Spector,et al. Epigenetics of discordant monozygotic twins: implications for disease , 2014, Genome Medicine.
[19] A. Singleton,et al. Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers , 2014, Brain : a journal of neurology.
[20] J. Berg,et al. GCH1 heterozygous mutation identified by whole-exome sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia , 2014, Journal of Neurology.
[21] G. Stevanin. Spastic Paraplegia 11 , 2013, Definitions.
[22] G. Ebers,et al. Genetic, environmental and stochastic factors in monozygotic twin discordance with a focus on epigenetic differences , 2012, BMC Medicine.
[23] E. Werner,et al. Tetrahydrobiopterin: biochemistry and pathophysiology. , 2011, The Biochemical journal.
[24] Tim D. Spector,et al. A twin approach to unraveling epigenetics , 2011, Trends in genetics : TIG.
[25] A. Bentivoglio,et al. Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early‐onset levodopa‐responsive Parkinsonism , 2011, Movement disorders : official journal of the Movement Disorder Society.
[26] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[27] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[28] Michael K. Hutchinson,et al. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. , 2009, Brain : a journal of neurology.
[29] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[30] K. Bowling,et al. Direct Binding of GTP Cyclohydrolase and Tyrosine Hydroxylase , 2008, Journal of Biological Chemistry.
[31] Jan Gründemann,et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.
[32] Nenad Blau,et al. Mutations in the BH4‐metabolizing genes GTP cyclohydrolase I, 6‐pyruvoyl‐tetrahydropterin synthase, sepiapterin reductase, carbinolamine‐4a‐dehydratase, and dihydropteridine reductase , 2006, Human mutation.
[33] M. Zeviani,et al. GTP-cyclohydrolase I gene mutations in patients with autosomal dominant and recessive GTP-CH1 deficiency: Identification and functional characterization of four novel mutations , 2004, Journal of Inherited Metabolic Disease.
[34] M. Farrer,et al. Dopa‐responsive dystonia presenting with prominent isolated bilateral resting leg tremor: Evidence for a role of parkin? , 2003 .
[35] Andreas Bracher,et al. Biosynthesis of pteridines. Reaction mechanism of GTP cyclohydrolase I. , 2003, Journal of molecular biology.
[36] C. Vinson,et al. Classification of Human B-ZIP Proteins Based on Dimerization Properties , 2002, Molecular and Cellular Biology.
[37] H. Topka,et al. Mutations of GCH1 in Dopa-responsive dystonia , 2002, Journal of Neural Transmission.
[38] R. Huber,et al. Zinc plays a key role in human and bacterial GTP cyclohydrolase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] C. Klein. [Genetics of dystonia]. , 2000, Fortschritte der Neurologie-Psychiatrie.
[40] S J Kish,et al. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia , 1999, Neurology.
[41] R. Huber,et al. Histidine 179 Mutants of GTP Cyclohydrolase I Catalyze the Formation of 2-Amino-5-formylamino-6-ribofuranosylamino-4(3H)-pyrimidinone Triphosphate* , 1999, The Journal of Biological Chemistry.
[42] Takahiro Suzuki,et al. Molecular Genetics of Dopa-Responsive Dystonia , 1999, Biological chemistry.
[43] A. Weindl,et al. D2 receptor binding in dopa‐responsive dystonia , 1998, Annals of neurology.
[44] C. Marsden,et al. Dopa‐responsive dystonia: A clinical and molecular genetic study , 1998, Annals of neurology.
[45] R. Huber,et al. Active site topology and reaction mechanism of GTP cyclohydrolase I. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] N. Blau,et al. Characterization of Mouse and Human GTP Cyclohydrolase I Genes , 1995, The Journal of Biological Chemistry.
[47] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[48] N. Blau,et al. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia , 1984, European Journal of Pediatrics.
[49] M. Synofzik. Parkinsonism in neurodegenerative diseases predominantly presenting with ataxia. , 2019, International review of neurobiology.
[50] Michael K. Hutchinson,et al. Exhaustive analysis of BH 4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia , 2009 .